Enhancement by cyclo‐oxygenase inhibitors of platelet‐activating factor production in thapsigargin‐stimulated macrophages

British Journal of Pharmacology

Volumn 116, Issue 3, 1995, Pages 2141-2147

  Watanabe, Masako ^a   Yamada, Masateru ^a   Mue, Suetsugu ^a   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

arachidonic acid; cyclic AMP; ibuprofen; indomethacin; macrophage; naproxen; Platelet activating factor; prostaglandin E2; thapsigargin

Indexed keywords

ARACHIDONIC ACID; BUCLADESINE; CYCLIC AMP; IBUPROFEN; INDOMETACIN; NAPROXEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; THAPSIGARGIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

ANIMAL; ARACHIDONIC ACID; BUCLADESINE; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SYNERGISM; IBUPROFEN; INDOMETHACIN; MACROPHAGES, PERITONEAL; MALE; NAPROXEN; PLATELET ACTIVATING FACTOR; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TERPENES; THAPSIGARGIN;

EID: 0029127737     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb16423.x     Document Type: Article

References (45)

1. 2 and acetyltransferase activities during phagocytosis and ionophore stimulation
2. The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response
3. Platelet‐activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils
4. A rapid method of total lipid extraction and purification
5. The release of platelet‐activating factor from human endothelial cells in culture
6. Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia gargantea, x‐ray analysis of the 7, 11‐epoxide of thapsigargin
7. Absolute configuration of the histamine liberating sesquiterpene lactones thapsigargin and trilobolides
8. Platelet‐activating factor. Evidence for 1‐0‐alkyl‐2‐acetyl‐sn‐glyceryl‐3‐phosphorylcholine as the active component (a new class of lipid chemical mediators)
9. Lipid mediator synthesis in peritoneal macrophages from mice injected with immunostimulants
10. Influence of isoproterenol and phosphodiesterase inhibitors on platelet‐activating factor biosynthesis in the human neutrophil
11. Release of cyclic AMP from macrophages by stimulation with prostaglandins
12. Thapsigargin, a histamine secretagogue, is a non‐12‐O‐tetra‐decanoylphorbol‐13‐acetate (TPA) type tumor promoter in two‐stage mouse skin carcinogenesis
13. Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine
14. Activation of rabbit platelets by platelet‐activating factor derived from IgE‐sensitized basophils. Characteristics of the aggregation and its dissociation from secretion
15. Activation of platelets by platelet‐activating factor (PAF) derived from IgE‐sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF‐induced secretion
16. Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine
17. Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine
18. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues
19. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet‐activating factor
20. Stimulation of degranulation from human eosinophils by platelet‐activating factor
21. 2 and cAMP
22. The release of platelet‐activating factor by stimulated rabbit neutrophils
23. Fc receptor triggering induces expression of surface activation antigens and release of platelet‐activating factor in large granular lymphocytes
24. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine
25. Platelet‐activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes
26. Inflammatory actions of platelet‐activating factor (Paf‐acether) in guinea‐pig skin
27. 2 production by 12‐0‐tetradecanoylphorbol 13‐acetate (TPA)‐type and non‐TPA‐type tumor promoters in macrophages and its inhibition by cycloheximide
28. Synergistic stimulation of histamine release from rat peritoneal mast cells by 12‐O‐tetradecanoylphorbol 13‐acetate (TPA)‐type and non‐TPA‐type tumor promoters
29. Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non‐(12‐O‐tetradecanoylphorbol 13‐acetate) (TPA)‐type tumor promoter
30. Analysis of the stimulative effect of thapsigargin, a non‐TPA‐type tumour promoters, on arachidonic acid metabolism in rat peritoneal macrophages
31. Neutrophil responses to platelet‐activating factor
32. Human endothelial cells in culture produce platelet‐activating factor (l‐alkyl‐2‐acetyl‐M‐glycero‐3‐phosphocholine) when stimulated with thrombin
33. Platelet‐activating factor
34. Thapsigargin and thapsigargicin, two new histamine liberators from Thapsia gargantea L
35. 2+‐ATPase inhibitor thapsigargin
36. Platelet‐derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production
37. Role of E‐type prostaglandins in the regulation of interferon‐treated macrophage cytotoxic activity
38. Activation of human neutrophils with 1‐0‐hexadecyl/octadecyl‐2‐acetyl‐sn‐glycerol‐3‐phosphocholine (platelet activating factor)
39. Anaphylactic actions of platelet‐activating factor
40. The calcium mobilizing tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion
41. Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats
42. Possible role for platelet‐activating factor in neutrophil infiltration in allergic inflammation in rats
43. Preparation of immunoaffinity mini‐columns for the analysis of platelet activating factor (PAF) in biological samples
44. Enzymatic synthesis of 1‐alkyl‐2‐acetyl‐M‐glycero‐3‐phosphocholine, a hypotensive and platelet‐aggregating lipid
45. 2‐induced activation of adenosine 3′‐5′ cyclic monophosphate‐dependent‐protein kinases of a murine macrophage‐like cell Une (P388D1)